Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Share this article:
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge
Mad Men's Hendricks named the face of the LATISSE Wishes Challenge

Emmy-nominated actress Christina Hendricks, of Mad Men fame, has signed on as the spokesperson for the LATISSE Wishes Challenge, co-launched by Allergan, LATISSE's manufacturer, and the Make-a-Wish Foundation. For the second year running, the pharma company and the non-profit have teamed up to raise money on behalf of the foundation, with this year's goal of raising $500,000 to grant a wish in every Make-A-Wish chapter across the country.

“I've always felt my lashes were short and thin, and in my profession, I wear a lot of false lashes and makeup, which take a toll. So when LATISSE became available, I was curious to learn more,” said Hendricks in a statement. “LATISSE is also a brand that contributes to children, and I couldn't think of a better cause to support than the Make-A-Wish Foundation.”

Consumers can participate in the Challenge by donating a minimum of $20 to the Make-a-Wish Foundation through the campaign's website. LATISSE will double all donations up to $250,000 until November 30 of this year. For extra incentive, the first 10,000 participants to commit to the minimum donation will receive a LATISSE free trial certificate, which they can then discuss the benefits of with their doctor.

"Allergan is proud to continue its commitment to the Make-A-Wish Foundation,” said David Pyott, Chairman of the Board, President and CEO of Allergan, in a statement. “In just two years, LATISSE and the women across the country who use it have raised nearly $1.5 million to help the Make-A-Wish Foundation grant children's wishes. Women appreciate supporting a brand that gives back and that may also provide a solution for themselves. Through the LATISSE Wishes Challenge, women will join Hendricks to support a wonderful cause and learn more about LATISSE to see if it is right for them."

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.

Five things for Pharma Marketers to Know: Thursday, August 28

Five things for Pharma Marketers to Know: Thursday, ...

Human testing of GSK's Ebola virus starts next week, menopause is a costly healthcare concern, and a small conversation with pharmacists may have a big impact.